Abstract
The serum ferritin concentration is increased in both acute myeloblastic leukaemia and Hodgkin's disease. In acute leukaemia the mean concentration is about ten times the normal level and is associated with a high concentration of transferrin-bound iron. In Hodgkin's disease abnormal ferritinaemia is associated with a low concentration of transferrin-bound iron and appears to result from a block of reticuloendothelial iron release. Increased concentrations of circulating ferritin have also been observed in a few cases of chronic leukaemia and myelomatosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Jones, P., Miller, F., Worwood, M. et al. Ferritinaemia in Leukaemia and Hodgkin's Disease. Br J Cancer 27, 212–217 (1973). https://doi.org/10.1038/bjc.1973.26
Issue Date:
DOI: https://doi.org/10.1038/bjc.1973.26
This article is cited by
-
Ferritin concentrations in patients with differentiated thyroid cancer
Journal of Endocrinological Investigation (2000)
-
An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis
Biological Trace Element Research (1994)
-
Clinical significance of serum iron and ferritin in patients with colorectal cancer
Journal of Gastroenterology (1994)
-
Minor and trace elemental contents of cancerous breast tissue measured by instrumental and radiochemical neutron activation analysis
Biological Trace Element Research (1990)
-
Body iron status in critically ill patients: significance of serum ferritin
Intensive Care Medicine (1989)
